D-0280-2022 Class I Terminated
FDA drug recall D-0280-2022 was initiated by Teligent Pharma, Inc. on Oct 12, 2021 and is designated Class I. Reason for recall: Superpotent Drug The recall status is terminated (terminated Jun 18, 2024). Affected quantity: 52,104 glass bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Dec 22, 2021
- Initiation Date
- Oct 12, 2021
- Termination Date
- Jun 18, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 52,104 glass bottles
Product description
Lidocaine Hydrochloride Topical Solution USP 4% (40 mg/mL), 50 mL glass bottles, Rx Only, Teligent Pharma Inc., Buena, NJ 08310, NDC 52565-009-50
Reason for recall
Superpotent Drug
Distribution pattern
Nationwide within the United States
Code information
Lot #: 13262, Exp. 03/2022; 14217, Exp. 08/2022
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0280-2022
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026